These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9806017)

  • 21. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants.
    Martínez I; Dopazo J; Melero JA
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2419-29. PubMed ID: 9349460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G.
    Openshaw PJ; Clarke SL; Record FM
    Int Immunol; 1992 Apr; 4(4):493-500. PubMed ID: 1591217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic and genomic diversity of central European respiratory syncytial virus strains.
    Lukic-Grlic A; Cane PA; Bace A; Pringle CR; Mlinaric-Galinovic G; Popow-Kraupp T
    Arch Virol; 1998; 143(7):1441-7. PubMed ID: 9722887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus.
    Bastien N; Trudel M; Simard C
    Virology; 1997 Jul; 234(1):118-22. PubMed ID: 9234952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
    Hause AM; Henke DM; Avadhanula V; Shaw CA; Tapia LI; Piedra PA
    PLoS One; 2017; 12(4):e0175792. PubMed ID: 28414749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frameshifting and antigenic variation in respiratory syncytial virus.
    Cane PA
    Trends Microbiol; 1993 Jul; 1(4):156-9. PubMed ID: 8143132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains.
    Palomo C; Cane PA; Melero JA
    J Med Virol; 2000 Apr; 60(4):468-74. PubMed ID: 10686032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolutionary pattern of the G glycoprotein of human respiratory syncytial viruses from antigenic group B: the use of alternative termination codons and lineage diversification.
    Mart Nez I; Vald S O; Delfraro A; Arbiza J; Russi J; Melero JA
    J Gen Virol; 1999 Jan; 80 ( Pt 1)():125-130. PubMed ID: 9934694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection.
    Openshaw PJ; Anderson K; Wertz GW; Askonas BA
    J Virol; 1990 Apr; 64(4):1683-9. PubMed ID: 2319650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic and genetic variation in human respiratory syncytial virus.
    Wertz GW; Moudy RM
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S19-24. PubMed ID: 14730266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conservation of G-Protein Epitopes in Respiratory Syncytial Virus (Group A) Despite Broad Genetic Diversity: Is Antibody Selection Involved in Virus Evolution?
    Trento A; Ábrego L; Rodriguez-Fernandez R; González-Sánchez MI; González-Martínez F; Delfraro A; Pascale JM; Arbiza J; Melero JA
    J Virol; 2015 Aug; 89(15):7776-85. PubMed ID: 25995258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection.
    Cane PA; Thomas HM; Simpson AF; Evans JE; Hart CA; Pringle CR
    J Med Virol; 1996 Mar; 48(3):253-61. PubMed ID: 8801286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic diversity among respiratory syncytial viruses that have caused repeated infections in children from rural India.
    Parveen S; Broor S; Kapoor SK; Fowler K; Sullender WM
    J Med Virol; 2006 May; 78(5):659-65. PubMed ID: 16555275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of antibodies to respiratory syncytial virus attachment and nucleocapsid proteins with recombinant baculovirus-expressed antigens.
    Buraphacheep W; Britt WJ; Sullender WM
    J Clin Microbiol; 1997 Feb; 35(2):354-7. PubMed ID: 9003595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions.
    Taylor G; Thomas LH; Furze JM; Cook RS; Wyld SG; Lerch R; Hardy R; Wertz GW
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3195-206. PubMed ID: 9400970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of antibody against contemporary virus lineages of human respiratory syncytial virus sub-group A in infants and their mothers.
    McGill A; Greensill J; Craft AW; Fenwick F; Toms GL
    J Clin Virol; 2004 May; 30(1):73-80. PubMed ID: 15072758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of human respiratory syncytial virus genotype specific antibody responses in infants.
    McGill A; Greensill J; Marsh R; Craft AW; Toms GL
    J Med Virol; 2004 Nov; 74(3):492-8. PubMed ID: 15368511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polylactosaminoglycan modification of the respiratory syncytial virus small hydrophobic (SH) protein: a conserved feature among human and bovine respiratory syncytial viruses.
    Anderson K; King AM; Lerch RA; Wertz GW
    Virology; 1992 Nov; 191(1):417-30. PubMed ID: 1413513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Definition and functional analysis of the signal/anchor domain of the human respiratory syncytial virus glycoprotein G.
    Lichtenstein DL; Roberts SR; Wertz GW; Ball LA
    J Gen Virol; 1996 Jan; 77 ( Pt 1)():109-18. PubMed ID: 8558117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.
    Sparer TE; Matthews S; Hussell T; Rae AJ; Garcia-Barreno B; Melero JA; Openshaw PJ
    J Exp Med; 1998 Jun; 187(11):1921-6. PubMed ID: 9607931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.